Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Key Points: Enrichment of atypical MPL mutations in essential thrombocythemia. MPLS204P and MPLY591N mutants are weak gain-of-function mutants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
Genovese, G., Kähler, A. K., Handsaker, R. E., Lindberg, J., Rose, S. A., Bakhoum, S. F., Chambert, K., Mick, E., Neale, B. M., Fromer, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1409405 · Cited by 3,531
Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms
Klampfl, T., Gisslinger, H., Harutyunyan, A. S., Nivarthi, H., Rumi, E., Milosevic, J. D., Them, N. C. C., Berg, T., Gisslinger, B., Pietra, D., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1311347 · Cited by 2,003 · cited 5×
“© 2016 by The American Society of Hematology BLOOD, 21 JANUARY 2016 x VOLUME 127, NUMBER 3 333 KDEL.15,16Whereas wild-type (WT) CALR is essentially involved in the quality control of proteins and in calcium storage in the ER,17 the CALR mutants are able to activate the JAK2/STAT pathway via an unknown mechanism like t…”
BackgroundMethodInfluentialAge-related mutations associated with clonal hematopoietic expansion and malignancies
Xie, M., Lu, C., Wang, J., McLellan, M. D., Johnson, K. J., Wendl, M. C., McMichael, J. F., Schmidt, H. K., Yellapantula, V., Miller, C. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3733 · Cited by 1,874
Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2
Nangalia, J., Massie, C. E., Baxter, E. J., Nice, F. L., Gundem, G., Wedge, D. C., Avezov, E., Li, J., Kollmann, K., Kent, D. G., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1312542 · Cited by 1,756 · cited 4×
“Candidate mutations observed in the exon sequencing were validated using Sanger sequencing.(15,16,26) MPL and JAK2 gene sequencing”
BackgroundMethodInfluentialLeukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis
McKerrell, T., Park, N., Moreno, T., Grove, C. S., Ponstingl, H., Stephens, J., Crawley, C., Craig, J., Scott, M. A., Hodkinson, C., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.005 · Cited by 534
Dissecting the thrombopoietin receptor: Functional elements of the Mpl cytoplasmic domain
Drachman, J. G., & Kaushansky, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2350 · Cited by 153 · cited 1×
“Furthermore, this tyrosine is also phosphorylated after TPO binding, and negatively regulates MPL signaling by promoting its internalization degradation as well as ERK signaling.(46,47) 48 Asparagine is a polar residue in contrast to the negative charge represented by tyrosine phosphorylation and thus the Y591N mutati…”
Background
Cited by
Barbui, T., Thiele, J., Gisslinger, H., Kvasnicka, H. M., Vannucchi, A. M., Guglielmelli, P., Orazi, A., & Tefferi, A. (2018) · Blood Cancer Journal · doi:10.1038/s41408-018-0054-y · Cited by 641
Classification and Personalized Prognosis in Myeloproliferative Neoplasms
Grinfeld, J., Nangalia, J., Baxter, E. J., Wedge, D. C., Angelopoulos, N., Cantrill, R., Godfrey, A. L., Papaemmanuil, E., Gundem, G., MacLean, C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716614 · Cited by 631
Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms
Vainchenker, W., & Kralovics, R. (2017) · Blood · doi:10.1182/blood-2016-10-695940 · Cited by 616
Self-citationSpivak, J. L. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1406186 · Cited by 404
Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms
Rumi, E., & Cazzola, M. (2017) · Blood · doi:10.1182/blood-2016-10-695957 · Cited by 258
Metadata
- Authors
- Cabagnols, X., Favale, F., Pasquier, F., Messaoudi, K., Defour, J. P., Ianotto, J. C., Marzac, C., Le Couédic, J. P., Droin, N., Chachoua, I., Favier, R., Diop, M. K., Ugo, V., Casadevall, N., Debili, N., Raslova, H., Bellanné-Chantelot, C., Constantinescu, S. N., Bluteau, O., Plo, I., & Vainchenker, W.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2016-01-21
- Volume
- 127
- Issue
- 3
- Pages
- 333-342
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2187320767
- Cited by
- 197
- References
- 7
- FWCI
- 10.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients. https://app.cochat.ai/papers/10.1182/blood-2015-07-661983
- The paper
- Cabagnols, X., Favale, F., Pasquier, F., Messaoudi, K., Defour, J. P., Ianotto, J. C., Marzac, C., Le Couédic, J. P., Droin, N., Chachoua, I., Favier, R., Diop, M. K., Ugo, V., Casadevall, N., Debili, N., Raslova, H., Bellanné-Chantelot, C., Constantinescu, S. N., Bluteau, O., . . . Vainchenker, W. (2016). Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients. Blood. https://doi.org/10.1182/blood-2015-07-661983
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.